Wellbiotec Co., Ltd. (010600.KS)
ValueMarkers Composite Index
DCF data not available
Wellbiotec Co., Ltd. (010600.KS) — VMCI valuation read
Across 120 indicators, Wellbiotec Co., Ltd. (010600.KS) lands at VMCI 47/100. The Consumer Cyclical sector median is 50, so the 3-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.
No material Form 4 disclosures landed on 010600.KS in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.
**Investor frame.** On Value, 010600.KS trades at 21.0x earnings, 17% above the Consumer Cyclical median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 17.0% sits 7.0pp above the Consumer Cyclical median (10.0%). On Risk, net debt to EBITDA of 0.9x leaves covenant headroom for 010600.KS on the trailing balance sheet.
010600.KS fell 3.6% over the trailing 7 days, with a -12.1% read on a 30-day basis.
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, bags, car seats, and handle covers. It also offers logistics consulting, container, warehouse/clearance, and transportation agency services; product research and development, consulting, distribution, and sales; and general and specialized medicines, health functional products, diagnosis kits, cosmeceuticals, and other products. In addition, the company is involved in casting agency, celebrity development, content production, and multi-channel network; and food and beverages businesses. The company was founded in 1975 and is headquartered in Seoul, South Korea.
Related Stocks in Consumer Cyclical
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.